Dilly, Suzanne J. http://orcid.org/0000-0002-5861-6794
Morris, George S.
Taylor, Paul C.
Parmentier, Frederic
Williams, Coralie
Afshar, Mohammad
Article History
First Online: 9 January 2019
Compliance with Ethical Standards
:
: This study was funded by ValiSeek Limited, a subsidiary of Valirx plc, London, UK.
: SJD is employed by and is a shareholder and director of ValiSeek Limited, and is also a shareholder and director of Tangent Reprofiling Limited. PCT is a shareholder and director of Tangent Reprofiling Limited. GSM is employed by and is a director and shareholder of Valirx plc, and is a director of ValiSeek. MA is employed by and is a shareholder of Ariana Pharmaceuticals, Paris, France. FP and CW are employed by Ariana Pharmaceuticals, Paris, France.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee. The principles of GCP were applied throughout and the study was completed according to the guidelines of the Declaration of Helsinki (1964) and later amendments. Local ethics approval was sought at each site for the initial protocol and for protocol amendments.
: Informed consent forms were signed and dated by all patients and investigators prior to enrolment in the study. All patients were made aware of their rights and their ability to withdraw consent to any procedures at any time and without prejudice.